Farley did not elaborate on his views, but he is hardly the only Fortune 500 CEO who believes AI could spell trouble for ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

Moderna stock veered higher Monday after its flu shot proved to be as effective as older technology in a final-phase study.

It’s been a whirlwind year for Stéphane Bancel. Just over a year ago in March 2020, the World Health Organization declared the Covid-19 outbreak a pandemic. That same month Moderna, the biotech ...

Moderna CEO Stéphane Bancel, a veteran biotech executive whose fortune swelled during the Covid-19 pandemic, on Tuesday revealed he would donate all the after-tax proceeds from his original ...

In the face of senators’ criticism, Moderna CEO Stéphane Bancel did not agree to lower the commercial cost of the company’s Covid-19 vaccine in a hearing Wednesday on the vaccine’s price.

After another year of transformational revenue from the company's COVID-19 vaccine, Moderna has rewarded CEO Stéphane Bancel with a pay package of $19.4 million, according to a proxy statement (PDF).

Moderna CEO Stéphane Bancel and Sen. Bernie Sanders sparred over how much the company owes the federal government for its investment in developing the company’s Covid-19 vaccine.

Moderna CEO Stéphane Bancel made almost $400 million in 2022, although nearly all of that remains earmarked for unknown charities. Skip to Main Content. RFK Jr. Vaccines. research.

However, Bancel did not "dump" $400 million worth of Moderna stock all at once in February 2022. Bancel had sold less than $10 million worth of shares by mid-month, about $390 million less than ...